Vorinostat does not improve outcome in patients with acute myeloid leukemia and high risk myelodysplasia treated with azacitidine: Results of the UK Trials Acceleration Programme Ravva Trial

Бібліографічні деталі
Автори:	Craddock, C, Houlton, A, Ferguson, P, Raghavan, M, Fox, S, Dudley, L, Quek, L, Cavenagh, J, Dennis, M, McMullin, M, Pillai, S, Kelly, R, Siddique, S, Wheatley, K, Vyas, P
Формат:	Conference item
Опубліковано:	American Society of Hematology 2016

Схожі ресурси